NEW YORK, Sept. 27, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers.  Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. 

Kuehn Law, PLLC (PRNewsfoto/Kuehn Law, PLLC)

Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: 

  • Revance Therapeutics, Inc. (NASDAQ: RVNC) Click to Learn More

Revance Therapeutics, Inc. has entered into a definitive agreement with Crown Laboratories, Inc. for $6.66 per share in cash.

  • Rafael Holdings, Inc. (NYSE: RFL) Click to Learn More

Rafael Holdings, Inc. has agreed to merge with Cyclo Therapeutics. Upon completion of the merger, Rafael Holdings will issue Class B common stock to Cyclo Therapeutics shareholders, with Cyclo shares valued at $0.95 each.

  • Better Choice Company, Inc. (NYSE: BTTR) Click to Learn More

Better Choice Company, Inc. is set to merge with SRx Health Solutions Inc. After the proposed transaction is finalized, Better Choice shareholders will hold about 15% of the merged company.

  • ARC Document Solutions, ,Inc. (NYSE: ARC)  Click to Learn More

ARC Document Solutions has agreed to merge with TechPrint Holdings, LLC, an affiliate of ARC executives, for $3.40 per share.  

Why Your Participation Matters:

SHAREHOLDER CASES: ADDRESSING THE INJUSTICE

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.

How to Get Involved:

Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact the Firm at moon@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients.  Shareholders are advised to act promptly, as legal rights may be time-sensitive.  For additional information, please visit Merger Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:

Moon K. Young
Chief of Operations
Kuehn Law, PLLC
53 Hill Street, Suite 605
Southampton, NY 11968
moon@kuehn.law
(833) 672-0814

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-rvnc-rfl-bttr-and-arc-investors-to-contact-law-firm-302260853.html

SOURCE Kuehn Law, PLLC

Copyright 2024 PR Newswire

Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Revance Therapeutics Charts.
Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Revance Therapeutics Charts.